The Trump administration announced it will restrict approval for seasonal COVID-19 vaccines to seniors and individuals with specified health risks, directing more studies for healthier people. This change represents a significant departure from the previous policy advocating annual vaccinations for all individuals 6 months and older. The FDA emphasizes the need for substantial research before extending access to those outside high-risk groups, raising concerns over vaccination access amidst ongoing uncertainty about the benefits for the general public. Key officials highlighted the complexity of determining eligibility under the new guidelines.
"For many Americans we simply do not know the answer as to whether or not they should be getting the seventh or eighth or ninth or tenth COVID-19 booster."
"Is the pharmacist going to determine if you're in a high-risk group?" asked Dr. Paul Offit. "The only thing that can come of this will make vaccines less accessible."
Collection
[
|
...
]